Efficacy and safety of Tripterygium wilfordii Hook. f. for oral lichen planus: Evidence from 18 randomized controlled trials

被引:8
作者
Luo, Yue [1 ,2 ]
Kuai, Le [1 ,2 ]
Chen, Jia [3 ]
Sun, Xiaoying [2 ]
Liu, Liu [1 ]
Luo, Ying [1 ]
Ru, Yi [1 ]
Xing, Meng [1 ]
Ding, Xiaojie [1 ]
Zhou, Mi [1 ]
Li, Bin [1 ,2 ,4 ]
Li, Xin [1 ,2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Dermatol, Shanghai 200437, Peoples R China
[2] Shanghai Acad Tradit Chinese Med, Inst Dermatol, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Dermatol Hosp, Dept Dermatopathol, Shanghai, Peoples R China
[4] Shanxi TCM Hosp, Dept Dermatol, Xian, Peoples R China
关键词
combination therapy; glycosides; meta-analysis; oral lichen planus; topical glucocorticoids; Tripterygium wilfordii Hook; f; CLOBETASOL; TACROLIMUS; TRIPTOLIDE; MANAGEMENT; DISEASE;
D O I
10.1002/ptr.6672
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Glycosides from the roots of Tripterygium wilfordii Hook. f. are used for the treatment of oral lichen planus (OLP), a chronic inflammatory disease affecting the oral mucosa. To investigate the effectiveness and safety of Tripterygium glycosides (TGs) for OLP treatment, we conducted a systematic review of 18 randomized controlled trials, comprising 1,339 participants, from international and Chinese databases. We evaluated outcomes of TGs alone or in combination with conventional treatments. In combination with topical glucocorticoids (TGCs), including triamcinolone acetonide and prednisone, the total effectiveness rate (risk ratio [RR], 1.17; 95% confidence interval [CI], 1.09-1.25; p < .00001), symptom score reducing index (mean difference [MD], -2.44; 95% CI, -3.12 to -1.77; p < .0001), and visual analog scale score (MD, -1.61; 95% CI, -2.22 to -1.00; p < .0001) were significantly improved. Patients treated with TGs combined with TGCs experienced lower recurrence rates (RR, 0.37; 95% CI, 0.18-0.76; p = 0.007). The occurrence of adverse events was not significantly different between the TGs groups and controls. The combination of TG and TGCs improved clinical efficacy and reduced recurrence without increasing the risk of adverse events. A high-quality multicenter clinical study is needed to corroborate these findings.
引用
收藏
页码:2180 / 2191
页数:12
相关论文
共 51 条
[11]   Treatment of lichen planus - An evidence-based medicine analysis of efficacy [J].
Cribier, B ;
Frances, C ;
Chosidow, O .
ARCHIVES OF DERMATOLOGY, 1998, 134 (12) :1521-1530
[12]  
DING J, 2018, CHINESE BASIC MED, V25, P1549
[13]   Number V Oral lichen planus:: clinical features and management [J].
Eisen, D ;
Carrozzo, M ;
Sebastian, JVB ;
Thongprasom, K .
ORAL DISEASES, 2005, 11 (06) :338-349
[14]  
Gangeshetty N., 2015, World J. Stomatol, V4, P12, DOI [10.5321/wjs.v4.i1.12, DOI 10.5321/WJS.V4.I1.12]
[15]   Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases [J].
Han, Rui ;
Rostami-Yazdi, Martin ;
Gerdes, Sascha ;
Mrowietz, Ulrich .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) :424-436
[16]  
HAN XH, 2007, CHINA MED HERALD, V11, P74
[17]  
JIANG HJ, 2016, GEN J STOMATOLOGY, V3, P19
[18]   Lichen planus [J].
Lehman, Julia S. ;
Tollefson, Megha M. ;
Gibson, Lawrence E. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (07) :682-694
[19]  
LI J, 2018, CHINESE J DERMATOVEN, V17, P358
[20]  
LIAO JH, 2009, J PRACTICAL MED, V25, P2181